Commentary: Adverse event profiles of PARP inhibitors: analysis of spontaneous reports submitted to FAERS
- Resource Type
- article
- Source
- Frontiers in Pharmacology, Vol 14 (2023)
- Subject
niraparib PARP inhibitors pharmacovigilance FAERS lymphangioleiomyomatosis Therapeutics. Pharmacology RM1-950 - Language
- English
- ISSN
- 1663-9812